Publications

Publication

Placebo Response and Remission Rates in Randomised Trials of Induction and Maintenance Therapy for Ulcerative Colitis

September 8, 2017

Cochrane Database of Systematic Reviews
Publication

Alicaforsen for the Treatment of Inflammatory Bowel Disease

August 26, 2017

Expert Opinion on Investigational Drugs
Publication

Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease

August 3, 2017

Journal of Crohn's and Colitis
Publication

Reliability of EUS Indices to Detect Inflammation in Ulcerative Colitis

July 29, 2017

Gastrointestinal Endoscopy
Publication

Histologic Scoring Indices for Evaluation of Disease Activity in Crohn’s Disease

July 21, 2017

Cochrane Database of Systematic Reviews
Publication

The Development of a Magnetic Resonance Imaging Index for Fistulising Crohn’s Disease

June 27, 2017

Alimentary Pharmacology & Therapeutics
Publication

Pharmacokinetic Drug Evaluation of Budesonide in the Treatment of Crohn’s Disease

June 16, 2017

Expert Opinion on Drug Metabolism & Toxicology
Publication

Development of a Core Outcome Set for Clinical Trials in Inflammatory Bowel Disease: Study Protocol for a Systematic Review of the Literature and Identification of a Core Outcome Set Using a Delphi Survey

June 9, 2017

BMJ Open
Publication

A Comparison of Approaches for Adjudicating Outcomes in Clinical Trials

June 8, 2017

Trials
Publication

Randomised Non-inferiority Trial: 1600 MG Versus 400 MG Tablets of Mesalazine for the Treatment of Mild-To-Moderate Ulcerative Colitis

June 1, 2017

Alimentary Pharmacology & Therapeutics

Ready to Build a Better Trial?

When you need deep scientific expertise and global operational excellence to ensure trial success, you need to partner with the specialized gastrointestinal CRO. 

Talk to a GI Trial Expert